Compare ALEMBIC PHARMA with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA NATCO PHARMA ALEMBIC PHARMA/
NATCO PHARMA
 
P/E (TTM) x 16.6 35.1 47.4% View Chart
P/BV x 6.6 5.0 132.5% View Chart
Dividend Yield % 0.6 0.7 85.2%  

Financials

 ALEMBIC PHARMA   NATCO PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
NATCO PHARMA
Mar-19
ALEMBIC PHARMA/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs664849 78.2%   
Low Rs412557 74.0%   
Sales per share (Unadj.) Rs208.7573.8 36.4%  
Earnings per share (Unadj.) Rs31.0176.0 17.6%  
Cash flow per share (Unadj.) Rs37.1198.2 18.7%  
Dividends per share (Unadj.) Rs5.506.25 88.0%  
Dividend yield (eoy) %1.00.9 114.9%  
Book value per share (Unadj.) Rs144.2842.7 17.1%  
Shares outstanding (eoy) m188.5236.50 516.5%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.61.2 210.5%   
Avg P/E ratio x17.44.0 434.7%  
P/CF ratio (eoy) x14.53.5 408.9%  
Price / Book Value ratio x3.70.8 447.4%  
Dividend payout %17.73.6 499.6%   
Avg Mkt Cap Rs m101,46125,660 395.4%   
No. of employees `000NA5.0 0.0%   
Total wages/salary Rs m7,4673,559 209.8%   
Avg. sales/employee Rs ThNM4,225.3-  
Avg. wages/employee Rs ThNM718.0-  
Avg. net profit/employee Rs ThNM1,295.9-  
INCOME DATA
Net Sales Rs m39,34720,945 187.9%  
Other income Rs m941,302 7.2%   
Total revenues Rs m39,44122,247 177.3%   
Gross profit Rs m8,7367,948 109.9%  
Depreciation Rs m1,152810 142.3%   
Interest Rs m184193 95.4%   
Profit before tax Rs m7,4938,247 90.9%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5681,823 86.0%   
Profit after tax Rs m5,8446,424 91.0%  
Gross profit margin %22.237.9 58.5%  
Effective tax rate %20.922.1 94.6%   
Net profit margin %14.930.7 48.4%  
BALANCE SHEET DATA
Current assets Rs m19,57723,472 83.4%   
Current liabilities Rs m14,8967,287 204.4%   
Net working cap to sales %11.977.3 15.4%  
Current ratio x1.33.2 40.8%  
Inventory Days Days9092 97.3%  
Debtors Days Days4588 51.4%  
Net fixed assets Rs m27,09718,648 145.3%   
Share capital Rs m377365 103.3%   
"Free" reserves Rs m26,81134,525 77.7%   
Net worth Rs m27,18830,760 88.4%   
Long term debt Rs m4,9930-   
Total assets Rs m47,77843,031 111.0%  
Interest coverage x41.743.7 95.4%   
Debt to equity ratio x0.20-  
Sales to assets ratio x0.80.5 169.2%   
Return on assets %12.615.4 82.0%  
Return on equity %21.520.9 102.9%  
Return on capital %23.627.4 86.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,45311,536 168.6%   
Fx outflow Rs m6,0652,939 206.4%   
Net fx Rs m13,3888,597 155.7%   
CASH FLOW
From Operations Rs m8,1206,688 121.4%  
From Investments Rs m-7,556-6,122 123.4%  
From Financial Activity Rs m590-509 -116.0%  
Net Cashflow Rs m1,15366 1,747.4%  

Share Holding

Indian Promoters % 74.1 52.0 142.4%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 2.9 7.8 37.0%  
FIIs % 9.1 16.6 54.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 26.0 53.5%  
Shareholders   49,328 25,395 194.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   FULFORD INDIA  VENUS REMEDIES  CIPLA  WOCKHARDT  AUROBINDO PHARMA  

Compare ALEMBIC PHARMA With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex, Nifty Snap 4-Day Winning Streak; JSW Steel and Hindalco Among Top Losers(Closing)

Indian share markets witnessed selling pressure throughout the day today and ended lower.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

NATCO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 34.5% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 34.5% YoY). Sales on the other hand came in at Rs 5 bn (down 13.4% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 33.3% (Quarterly Result Update)

Jan 23, 2020 | Updated on Jan 23, 2020

For the quarter ended December 2019, ALEMBIC PHARMA has posted a net profit of Rs 2 bn (up 33.3% YoY). Sales on the other hand came in at Rs 12 bn (up 18.8% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 25.2% (Quarterly Result Update)

Nov 1, 2019 | Updated on Nov 1, 2019

For the quarter ended September 2019, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 25.2% YoY). Sales on the other hand came in at Rs 12 bn (up 10.1% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

More Views on News

Most Popular

The Next Smallcap Winners(Profit Hunter)

Apr 30, 2021

Price is the only due diligence one might require to buy this business.

Time to Buy Smallcaps?(Fast Profits Daily)

Apr 30, 2021

In this video, I'll show you why I favour smallcaps over the Nifty.

Sell in May and Go Away?(Fast Profits Daily)

Apr 28, 2021

Does the concept of selling stocks in the month of May, work in the Indian market?

Are the Stock Markets Deaf to Covid Agony?(Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


May 11, 2021 03:36 PM

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS